Management ChangeJun 12, 2026, 05:01 PM
BioRestorative Therapies Extends Employment Agreement with VP R&D Francisco Silva
AI Summary
BioRestorative Therapies, Inc. has entered into a new three-year employment agreement with its Vice President of Research and Development, Francisco Silva. The agreement, effective June 10, 2026, maintains his current annual salary of $575,000 and outlines terms for compensation, benefits, termination, and post-employment restrictions. The filing also details exhibits including the full employment agreement and a cover page interactive data file.
Key Highlights
- BioRestorative Therapies, Inc. entered into an employment agreement with Francisco Silva, VP of R&D.
- The agreement is effective from June 10, 2026, to June 10, 2029.
- Francisco Silva's annual salary remains $575,000.
- The agreement includes provisions for salary, discretionary bonus, benefits, expense reimbursement, and option grants.
- Termination clauses cover resignation, death, disability, termination for cause, and termination without cause.
- The agreement includes confidentiality, non-disclosure, and restrictive covenants for one year post-termination.
- Developments and inventions made during employment are the sole property of the Company.
Price Impact
More from BRTX